Cargando…
Protocol for a Cross-Sectional Study: Effects of a Multiple Sclerosis Relapse Therapy With Methylprednisolone on Offspring Neurocognitive Development and Behavior (MS-Children)
INTRODUCTION: Multiple Sclerosis (MS) is the most common neuroimmunological disease in women of childbearing age. Current MS therapy consists of immunomodulatory relapse prevention with disease-modifying therapies (DMTs) and acute relapse therapy with the synthetic glucocorticoid (GC) methylpredniso...
Autores principales: | Kozik, Valeska, Schwab, Matthias, Thiel, Sandra, Hellwig, Kerstin, Rakers, Florian, Dreiling, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087857/ https://www.ncbi.nlm.nih.gov/pubmed/35557615 http://dx.doi.org/10.3389/fneur.2022.830057 |
Ejemplares similares
-
Erratum: Protocol for a cross-sectional study: effects of a multiple sclerosis relapse therapy with methylprednisolone on offspring neurocognitive development and behavior (MS-children)
Publicado: (2023) -
Characterization of neurocognitive deficits in patients with post-COVID-19 syndrome: persistence, patients’ complaints, and clinical predictors
por: Kozik, Valeska, et al.
Publicado: (2023) -
Association between antenatal glucocorticoid exposure and the activity of the stress system, cognition, and behavior in 8‐ to 9‐year‐old children: A prospective observational study
por: Rakers, Florian, et al.
Publicado: (2022) -
Relapsing and progressive MS: the sex-specific
perspective
por: Rommer, Paulus Stefan, et al.
Publicado: (2020) -
Eighteen-month safety analysis of offspring breastfed by mothers
receiving glatiramer acetate therapy for relapsing multiple sclerosis – COBRA
study
por: Ciplea, Andrea Ines, et al.
Publicado: (2022)